Cargando…

Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy

Robust and clinically convenient biomarkers for cancer diagnosis, early detection, and prognosis have great potential to improve patient survival and are the key to precision medicine. The advent of next-generation sequencing technologies enables a more sensitive and comprehensive profiling of genet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Chang, Stroup, Emily Kunce, Zhang, Zhou, Chiu, Brian C.-H., Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440138/ https://www.ncbi.nlm.nih.gov/pubmed/30922396 http://dx.doi.org/10.1186/s40880-019-0356-x

Ejemplares similares

Circular RNA in liquid biopsy as biomarkers toward precision medicine
por: Lee, Yueh-Chun, et al.
Publicado: (2023)

Application of the High-Throughput TAB-Array for the Discovery of Novel 5-Hydroxymethylcytosine Biomarkers in Pancreatic Ductal Adenocarcinoma
por: Zeng, Chang, et al.
Publicado: (2019)

Liquid Biopsy: A Biomarker-Driven Tool towards Precision Oncology
por: Yee, Nelson S.
Publicado: (2020)

Deep learning of human polyadenylation sites at nucleotide resolution reveals molecular determinants of site usage and relevance in disease
por: Stroup, Emily Kunce, et al.
Publicado: (2023)

Multiomic Approaches for Cancer Biomarker Discovery in Liquid Biopsies: Advances and Challenges
por: Diaz, Paola Monterroso, et al.
Publicado: (2023)

Liquid biopsy: a step forward towards precision medicine in urologic malignancies
por: Di Meo, Ashley, et al.
Publicado: (2017)

Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma
por: Cai, Z., et al.
Publicado: (2021)

“Liquid biopsy” - extracellular vesicles as potential novel players towards precision medicine in asthma
por: Ambrożej, Dominika, et al.
Publicado: (2022)

Precision Medicine for Colorectal Cancer with Liquid Biopsy and Immunotherapy
por: Nagayama, Satoshi, et al.
Publicado: (2021)

Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma
por: Cai, Jiabin, et al.
Publicado: (2019)

Liquid biopsies for multiple myeloma in a time of precision medicine
por: Ferreira, Bruna, et al.
Publicado: (2020)

Liquid Biopsy as Novel Tool in Precision Medicine: Origins, Properties, Identification and Clinical Perspective of Cancer’s Biomarkers
por: Fernández-Lázaro, Diego, et al.
Publicado: (2020)

Advances in molecular biomarkers and liquid biopsy in gliomas
por: Mathios, Dimitrios, et al.
Publicado: (2022)

Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach
por: Ricciardi, Elena, et al.
Publicado: (2023)

Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine
por: Luchini, Claudio, et al.
Publicado: (2019)

Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine
por: Beger, Richard D., et al.
Publicado: (2020)

Introduction to this Special Issue: “Biomarker Discovery and Precision Medicine”
por: Fang, Bingliang
Publicado: (2020)

Liquid Biopsies in Colorectal Liver Metastases: Towards the Era of Precision Oncologic Surgery
por: Tsilimigras, Diamantis I., et al.
Publicado: (2022)

Advances of Osteosarcoma Models for Drug Discovery and Precision Medicine
por: Tan, Linyun, et al.
Publicado: (2023)

Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology
por: Asleh, Karama, et al.
Publicado: (2023)

Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet?
por: Mirza, Sheefa, et al.
Publicado: (2023)

Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology
por: Hampel, Harald, et al.
Publicado: (2019)

Liquid biopsy: expanding the frontier of circulating biomarker discovery and validation in breast cancer
por: Miller, Philip C., et al.
Publicado: (2019)

Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine
por: Wu, Xingyun, et al.
Publicado: (2023)

Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer
por: Hu, Xinlei, et al.
Publicado: (2022)

Precise genomic mapping of 5-hydroxymethylcytosine via covalent tether-directed sequencing
por: Gibas, Povilas, et al.
Publicado: (2020)

Liquid biopsy: Precise diagnosis and therapy for cholangiocarcinoma
por: Wang, Si-Qin, et al.
Publicado: (2022)

Redefining precision radiotherapy through liquid biopsy
por: McLaren, D. B., et al.
Publicado: (2023)

Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine
por: Meehan, James, et al.
Publicado: (2021)

Editorial: Pharmacometabolomics: biomarker discovery, precision medicine, technical advances, perspectives and future applications in respiratory diseases
por: Vignoli, Alessia, et al.
Publicado: (2023)

Current advances of liquid biopsies in prostate cancer: Molecular biomarkers
por: Alahdal, Murad, et al.
Publicado: (2023)

Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery
por: Lee, Bongyong, et al.
Publicado: (2020)

Liquid biopsy: from discovery to clinical implementation
por: Alix‐Panabières, Catherine, et al.
Publicado: (2021)

DMET(TM) Genotyping: Tools for Biomarkers Discovery in the Era of Precision Medicine
por: Agapito, Giuseppe, et al.
Publicado: (2020)

Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the COVID-19 Pandemic
por: Napolitano, Stefania, et al.
Publicado: (2022)

Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer
por: Caputo, Vincenza, et al.
Publicado: (2023)

Liquid biopsy for cancer management: a revolutionary but still limited new tool for precision medicine
por: Arechederra, María, et al.
Publicado: (2020)

Tissue-specific 5-hydroxymethylcytosine landscape of the human genome
por: He, Bo, et al.
Publicado: (2021)

Application of annotation-agnostic RNA sequencing data analysis tools for biomarker discovery in liquid biopsy
por: Wajnberg, Gabriel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kepd061teafg4pvdt9482fijvu